drugset / Trial / NCT00612560
Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics
Completed
28 enrolled
Roswell Park Cancer Institute
AstraZeneca · collabNational Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedFactorialQuadruple-blindBasic science
Summary
The proposed study plans to examine the effect of flaxseed consumption, a phytoestrogen rich food, compared to aromatase inhibitors as a complementary approach to treating estrogen receptor positive breast cancer, as well as the effect of combined flaxseed and aromatase inhibitor therapy on breast cancer treatment. Because of the increasing use of both complementary and alternative approaches to treatment, and the use of aromatase inhibitors in the treatment of breast cancer, the proposed study has potential to provide important clinical information about the effect of foods high in phytoestrogens on a common endocrine therapy used in breast cancer.
Timeline
- Start
- 2007-11
- Primary completion
- 2011-01
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | 1 mg | — |